Discovery of potential lumazine synthase antagonists for pathogens involved in bacterial meningitis: In silico study

Bacterial meningitis, an infection of the membranes (meninges) and cerebrospinal fluid (CSF) surrounding the brain and spinal cord, is a major cause of death and disability worldwide. Streptococcus pneumonia, Neisseria meningitidis, Haemophilus influenzae type b and Staphylococcus aureus are the pre...

Full description

Bibliographic Details
Main Authors: Manne Munikumar, Pradeep Natarajan, Umamaheswari Amineni, K.V. Radha Krishna
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Informatics in Medicine Unlocked
Online Access:http://www.sciencedirect.com/science/article/pii/S2352914819300577
id doaj-5e7e3d8000b14ea6bfeffd123674f6bf
record_format Article
spelling doaj-5e7e3d8000b14ea6bfeffd123674f6bf2020-11-25T02:06:07ZengElsevierInformatics in Medicine Unlocked2352-91482019-01-0115Discovery of potential lumazine synthase antagonists for pathogens involved in bacterial meningitis: In silico studyManne Munikumar0Pradeep Natarajan1Umamaheswari Amineni2K.V. Radha Krishna3NIN-TATA Centre for Excellence in Public Health Nutrition, ICMR-National Institute of Nutrition, Jamai-Osmania (Post), Hyderabad, 500007, Telangana, India; Corresponding author.BIF Centre, Department of Biomedical Engineering, National Institute of Technology Rourkela, Odisha, 769008, IndiaBioinformatics Centre, Department of Bioinformatics, Sri Venkateswara Institute of Medical Sciences (SVIMS) University, Tirupati, 517507, Andhra Pradesh, India; Corresponding author.NIN-TATA Centre for Excellence in Public Health Nutrition, ICMR-National Institute of Nutrition, Jamai-Osmania (Post), Hyderabad, 500007, Telangana, IndiaBacterial meningitis, an infection of the membranes (meninges) and cerebrospinal fluid (CSF) surrounding the brain and spinal cord, is a major cause of death and disability worldwide. Streptococcus pneumonia, Neisseria meningitidis, Haemophilus influenzae type b and Staphylococcus aureus are the predominant pathogens of bacterial meningitis. In our previous study, we have identified lumazine synthase as a common drug target in pathogens of bacterial meningitis. The three dimensional (3D) structure of lumazine synthase complex with 5-nitro-6-ribityl-amino-2,4(1 h, 3 h)-pyrimidinedione (INI) was generated based on PDBID: 1RVV as a template using Modeller 9v12. Multiple docking strategies including rigid receptor docking (RRD), QPLD and IFD were performed for lumazine synthase with 29 existing inhibitors, and screened for 13050 ligands, respectively. Three stages of RRD (HTVS, SP, XP) were carried out using Glide v5.9 resulted in 134 leads. The 134 leads were compared to 29 inhibitors; eight best leads were obtained, which were further utilized for QPLD-MM-GBSA analysis. Eight compounds had a least docking score, lower binding free energy, and better binding orientation towards lumazine synthase. Furthermore, to analyse the stability of the lumazine synthase, the lead1 complex was subjected to 50 ns MD simulations and found to be stable. The results from multiple docking analysis and MD simulations affirmed that lead1 may be a promising inhibitor for efficient inhibition of lumazine synthase activity in common pathogens of bacterial meningitis. Keywords: Bacterial meningitis, Lumazine synthase, Rigid receptor docking, QM-Polarized ligand docking, Induced fit docking, Molecular dynamics simulationshttp://www.sciencedirect.com/science/article/pii/S2352914819300577
collection DOAJ
language English
format Article
sources DOAJ
author Manne Munikumar
Pradeep Natarajan
Umamaheswari Amineni
K.V. Radha Krishna
spellingShingle Manne Munikumar
Pradeep Natarajan
Umamaheswari Amineni
K.V. Radha Krishna
Discovery of potential lumazine synthase antagonists for pathogens involved in bacterial meningitis: In silico study
Informatics in Medicine Unlocked
author_facet Manne Munikumar
Pradeep Natarajan
Umamaheswari Amineni
K.V. Radha Krishna
author_sort Manne Munikumar
title Discovery of potential lumazine synthase antagonists for pathogens involved in bacterial meningitis: In silico study
title_short Discovery of potential lumazine synthase antagonists for pathogens involved in bacterial meningitis: In silico study
title_full Discovery of potential lumazine synthase antagonists for pathogens involved in bacterial meningitis: In silico study
title_fullStr Discovery of potential lumazine synthase antagonists for pathogens involved in bacterial meningitis: In silico study
title_full_unstemmed Discovery of potential lumazine synthase antagonists for pathogens involved in bacterial meningitis: In silico study
title_sort discovery of potential lumazine synthase antagonists for pathogens involved in bacterial meningitis: in silico study
publisher Elsevier
series Informatics in Medicine Unlocked
issn 2352-9148
publishDate 2019-01-01
description Bacterial meningitis, an infection of the membranes (meninges) and cerebrospinal fluid (CSF) surrounding the brain and spinal cord, is a major cause of death and disability worldwide. Streptococcus pneumonia, Neisseria meningitidis, Haemophilus influenzae type b and Staphylococcus aureus are the predominant pathogens of bacterial meningitis. In our previous study, we have identified lumazine synthase as a common drug target in pathogens of bacterial meningitis. The three dimensional (3D) structure of lumazine synthase complex with 5-nitro-6-ribityl-amino-2,4(1 h, 3 h)-pyrimidinedione (INI) was generated based on PDBID: 1RVV as a template using Modeller 9v12. Multiple docking strategies including rigid receptor docking (RRD), QPLD and IFD were performed for lumazine synthase with 29 existing inhibitors, and screened for 13050 ligands, respectively. Three stages of RRD (HTVS, SP, XP) were carried out using Glide v5.9 resulted in 134 leads. The 134 leads were compared to 29 inhibitors; eight best leads were obtained, which were further utilized for QPLD-MM-GBSA analysis. Eight compounds had a least docking score, lower binding free energy, and better binding orientation towards lumazine synthase. Furthermore, to analyse the stability of the lumazine synthase, the lead1 complex was subjected to 50 ns MD simulations and found to be stable. The results from multiple docking analysis and MD simulations affirmed that lead1 may be a promising inhibitor for efficient inhibition of lumazine synthase activity in common pathogens of bacterial meningitis. Keywords: Bacterial meningitis, Lumazine synthase, Rigid receptor docking, QM-Polarized ligand docking, Induced fit docking, Molecular dynamics simulations
url http://www.sciencedirect.com/science/article/pii/S2352914819300577
work_keys_str_mv AT mannemunikumar discoveryofpotentiallumazinesynthaseantagonistsforpathogensinvolvedinbacterialmeningitisinsilicostudy
AT pradeepnatarajan discoveryofpotentiallumazinesynthaseantagonistsforpathogensinvolvedinbacterialmeningitisinsilicostudy
AT umamaheswariamineni discoveryofpotentiallumazinesynthaseantagonistsforpathogensinvolvedinbacterialmeningitisinsilicostudy
AT kvradhakrishna discoveryofpotentiallumazinesynthaseantagonistsforpathogensinvolvedinbacterialmeningitisinsilicostudy
_version_ 1724934858568892416